1. Home
  2. Analysis
  3. Gabapentin
  4. Zecuity

Gabapentin and Zecuity drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Zecuity (sumatriptan succinate). Common drug interactions include application site erythema among females and application site erythema among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Zecuity. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Zecuity?

Zecuity has active ingredients of sumatriptan succinate. eHealthMe is studying from 3,104 Zecuity users. Check the latest studies of Zecuity.

On Jul, 11, 2026

31 people who take Gabapentin and Zecuity together, and have interactions are studied.

Gabapentin and Zecuity drug interactions.

What are the common drug interactions of Gabapentin and Zecuity, by gender? *:

female:

  1. Application site erythema (redness of the skin at application site)
  2. Application site pain
  3. Application site discolouration
  4. Application site irritation
  5. Application site paraesthesia (abnormal skin sensation of tingling, tickling, prickling, pricking, or burning felt at application site)
  6. Application site burn
  7. Application site pruritus (application site severe itching of the skin)
  8. Application site discomfort
  9. Application site rash
  10. Application site urticaria

male:

  1. Application site erythema (redness of the skin at application site)
  2. Application site pain
  3. Hypophagia (reduced food intake)
  4. Intracranial hypotension (low pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  5. Migraine (headache)
  6. Occipital neuralgia (a condition characterized by chronic pain in the upper neck)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Pneumonia
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Sinusitis (inflammation of sinus)

What are the common drug interactions of Gabapentin and Zecuity, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Skin discolouration (change of skin colour)
  2. Burning sensation

30-39:

  1. Application site erythema (redness of the skin at application site)
  2. Application site pain
  3. Application site discolouration
  4. Application site burn
  5. Application site urticaria
  6. Application site warmth
  7. Application site scar
  8. Application site irritation
  9. Application site discomfort
  10. Application site paraesthesia (abnormal skin sensation of tingling, tickling, prickling, pricking, or burning felt at application site)

40-49:

  1. Application site discolouration
  2. Application site erythema (redness of the skin at application site)
  3. Application site pruritus (application site severe itching of the skin)
  4. Application site burn
  5. Application site irritation
  6. Application site pain
  7. Application site papules (solid elevation of skin with no visible fluid at application site)
  8. Application site discomfort
  9. Application site inflammation
  10. Application site paraesthesia (abnormal skin sensation of tingling, tickling, prickling, pricking, or burning felt at application site)

50-59:

  1. Application site erythema (redness of the skin at application site)
  2. Application site pain
  3. Application site paraesthesia (abnormal skin sensation of tingling, tickling, prickling, pricking, or burning felt at application site)
  4. Application site irritation
  5. Application site discolouration
  6. Application site burn
  7. Application site pruritus (application site severe itching of the skin)
  8. Application site exfoliation (application site removal of the oldest dead skin cells on the skin's outermost surface)
  9. Application site scar
  10. Application site rash

60+:

  1. Application site erythema (redness of the skin at application site)
  2. Application site rash
  3. Application site dryness
  4. Application site exfoliation (application site removal of the oldest dead skin cells on the skin's outermost surface)
  5. Application site papules (solid elevation of skin with no visible fluid at application site)
  6. Application site paraesthesia (abnormal skin sensation of tingling, tickling, prickling, pricking, or burning felt at application site)
  7. Application site pruritus (application site severe itching of the skin)
  8. Chemical injury
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  10. Migraine (headache)

What are the existing conditions these people have? *

  1. Migraine (headache): 13 people, 41.94%
  2. Headache (pain in head): 12 people, 38.71%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Zecuity?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabapentin and Zecuity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zecuity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zecuity and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and sumatriptan succinate (the active ingredients of Gabapentin and Zecuity, respectively), and Gabapentin and Zecuity (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.